SCI
EXAS

Stableford Capital II’s Exact Sciences EXAS Stock Holding History

Stableford Capital II’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-3,539
Closed -$346K – 126
2021
Q3 		$346K Sell
3,539
-115
-3% -$12.1K 0.18% 102
2021
Q2 		$454K Buy
+3,654
New +$436K 0.22% 97

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Stableford Capital II's EXAS Position: Q4 2021 in Review

Stableford Capital II sold out of Exact Sciences (EXAS) in Q4 2021, closing a stake of 3,539 shares — an estimated $346K sold.

Stableford Capital II first reported a position in EXAS in Q2 2021 and held it in 2 quarters. The position peaked at $454K in Q2 2021. 596 funds tracked by Wall St. Rank hold EXAS as of Q4 2021.

  • Stableford Capital II reported no remaining Exact Sciences position as of Q4 2021 after selling out during the quarter.
  • Stableford Capital II sold 3,539 Exact Sciences shares in Q4 2021, an estimated $346K.
  • Stableford Capital II first reported a position in Exact Sciences in Q2 2021 and held it in 2 quarters.
  • Stableford Capital II's Exact Sciences position peaked at $454K in Q2 2021.
  • 596 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2021.

Based on Stableford Capital II's 13F filing for Q4 2021, filed 28 Jan 2022.